Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 9 May 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Although selling prices for the major mushroom products exceeded the forecast due to sales of new products and a strategic product mix, sales volume and mushroom production fell below expectations, resulting in revenue below forecast. Operating profit, profit before tax and profit for the year exceeded the forecast due to efficiency improvements through coordination between production and sales and cost control of selling, general and administrative expenses.
The disclosure states that the one-off impact of the impairment loss on the mushroom business recorded in the previous fiscal year has been eliminated. No amount was disclosed.
| Item | Details |
|---|---|
| Net Sales | ¥38,880 million → ¥37,845 million（△2.7%） |
| Operating profit | ¥3,270 million → ¥4,319 million（32.1%） |
| Profit attributable to owners of the parent | ¥2,010 million → ¥2,958 million（47.2%） |
| Net income per share | 50.39 yen and sen → 74.18 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 9 May 2025 |
| Previous-period results | Consolidated: revenue of ¥37,102 million, operating profit of ¥2,419 million, profit before tax of ¥2,175 million, profit for the year of ¥1,496 million, profit for the year attributable to owners of the parent of ¥1,502 million, and basic earnings per share of ¥37.66. Standalone: net sales of ¥34,486 million, operating profit of ¥2,427 million, ordinary profit of ¥2,229 million, net loss of ¥3 million, and earnings per share of negative ¥0.08. |
| Reason for the revision | Although selling prices for the major mushroom products exceeded the forecast due to sales of new products and a strategic product mix, sales volume and mushroom production fell below expectations, resulting in revenue below forecast. Operating profit, profit before tax and profit for the year exceeded the forecast due to efficiency improvements through coordination between production and sales and cost control of selling, general and administrative expenses. |
| Details and amount of extraordinary loss | The disclosure states that the one-off impact of the impairment loss on the mushroom business recorded in the previous fiscal year has been eliminated. No amount was disclosed. |
| Dividend forecast revision | The year-end dividend was set at ¥19 per share, an increase of ¥7 from the latest forecast of ¥12 per share. Total dividends amount to ¥917 million. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although selling prices rose as a result of sales of new products and the product mix, sales volume and mushroom production fell below expectations, resulting in revenue below forecast. On the profit side, business efficiency improvements through coordination between production and sales and cost control of selling, general and administrative expenses contributed to results. Standalone profit for the year also exceeded expectations because the one-off impact of the impairment loss on the mushroom business recorded in the previous fiscal year was no longer present. The dividend was increased based on business performance and the dividend policy.